The impact of body mass index (BMI) on treatment outcome of targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Cancer Database Consortium.Laurence Albigès, Toni K. Choueiri, D. Scott Ernst et al.|Journal of Clinical Oncology|2014Cited by 8
Metastatic non–clear cell renal cell carcinoma (nccRCC) treated with targeted therapy agents: Applying the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic model to predict outcomes.Nils Kroeger, Daniel Yick Chin Heng, Wanling Xie et al.|Journal of Clinical Oncology|2013Cited by 0
Treatment response and survival outcome of patients with late relapse (LR) from renal cell carcinoma (RCC) in the era of targeted therapy.Nils Kroeger, Daniel Yick Chin Heng, Jae‐Lyun Lee et al.|Journal of Clinical Oncology|2013Cited by 0